Viatris to Showcase Innovations at the 44th Annual J.P. Morgan Healthcare Conference

Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference

Viatris Inc. (Nasdaq: VTRS), a leader in the global healthcare sector, is set to present at the prestigious 44th Annual J.P. Morgan Healthcare Conference. This significant event will take place on January 13, 2026, in San Francisco. The company plans to share key insights during its presentation and engage in a fireside chat starting at 9 a.m. PT, which is noon ET.

This year’s conference expects a robust participation from industry leaders, investors, and healthcare professionals, providing a unique platform for Viatris to highlight its commitment to transforming healthcare. As a company dedicated to bridging the gap between generic and brand-name medications, Viatris aims to contribute to the ongoing discourse about access to medicines and innovations impacting patient care worldwide.

Viatris operates with a clear mission—to empower individuals to lead healthier lives at every stage. The company's diverse portfolio encompasses a wide range of effective medications which cater to approximately 1 billion patients globally each year. This, combined with an innovative supply chain, allows them to reach those in need, when and where they need it most.

Event Details

To join the live webcast of Viatris' presentation at the J.P. Morgan Healthcare Conference, participants can visit investor.viatris.com. The presentation will be archived and available for viewing after the event for a limited time, ensuring that all interested stakeholders are able to access the valuable insights shared during the session.

About Viatris

Founded through the merger of Mylan and Upjohn, Viatris blends the best practices of generics and brand pharmaceuticals. The company’s headquarters is located in the United States, with major operational hubs in Pittsburgh, Shanghai, and Hyderabad, India. This global presence facilitates widespread distribution and ensures that their products are available to a vast demographic, addressing both acute conditions and chronic diseases across diverse populations. Viatris prides itself on its scientific expertise and commitment to addressing long-standing health challenges, making healthcare access a significant part of its core mission.

Viatris continues to be a trailblazer in the industry, utilizing a strategic approach that emphasizes quality high-efficacy medicines and consistent patient access. The company recognizes its role in society goes beyond profits; it strives to affect positive changes that resonate throughout communities, fostering healthier populations.

For more insights into Viatris and its contributions to global healthcare, please visit their official website viatris.com and stay connected through their social platforms on LinkedIn, Instagram, YouTube, and X.